New publication – Anti-V1/V3-glycan broadly HIV-1 neutralizing antibodies in a post-treatment controller
Some HIV-positive patients off antiretroviral therapy can control their viremia on the long term. These so-called post-treatment controllers (PTCs) represent a unique opportunity to better understand how the human immune system can contain HIV-1 […]

















